Adiponectin, Leptin, h-CRP Values in Obese Children - Important Markers for Metabolic Syndrome? — ChildObes  

Obesity, Metabolically Benign Clinical Trial

Official title: Adiponectin, Leptin, h-CRP Values in Obese Children - Important Markers for Metabolic Syndrome?

Status Completed

Clinical Trial Summary

Obesity is a chronic inflammatory disorder in which leptin, adiponectin and C reactive protein (CRP) play an important role. This study aimed to investigate the relationship between markers of adiposity like leptin, adiponectin and high sensitive C reactive protein (hsCRP) in obese children, and to determine whether these adipokines are significant markers in defining metabolic syndrome in pediatric population

Clinical Trial Description

The idea that adipose tissue is just a form of energy storage has changed dramatically in recent years. Currently, adipose tissue is considered to be a true endocrine gland that fulfills multiple roles in regulating different biological functions. Communication between adipose tissue and the rest of the systems is accomplished through bioactive mediators (adipokines) Adipokines control energy homeostasis and are involved in metabolic, endocrine and immunological processes.This study aimed to investigate the relationship between markers of adiposity like leptin, adiponectin and high sensitive C reactive protein (hsCRP) in obese children, and to determine whether these adipokines are significant markers in defining metabolic syndrome in pediatric population.The current retrospective observational study was conducted at the "Louis Turcanu" Emergency Hospital Timisoara over a period of one year, from July 2013 and June 2014. All inborn patient files were analyzed as anonymised limited data sets from archived records of the Endocrinology, Diabetology and Cardiology department. ;

Related Conditions & MeSH terms

• Metabolic Syndrome X
• Obesity, Metabolically Benign

• NCT number: NCT03354676
• Study type: Observational
• Source: Romanian Society of Anesthesia and Intensive Care
• Status: Completed
• Phase: N/A
• Start date: March 11, 2016
• Completion date: September 10, 2017